Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (381-390 of 491) with videos related to

Pageof 50
Sort By:
NPJ Systems Biology and Applications|October 3, 2025
Enhancing randomized clinical trials with digital twinsHossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2021
Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicM Kasperkiewicz, E Schmidt, M Amagai, et al.
The Australasian Journal of Dermatology|April 2, 2015
Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological studyLynda Spelman, Diana Rubel, Dedee F Murrell, et al.
NPJ Systems Biology and Applications|November 6, 2025
Author Correction: Enhancing randomized clinical trials with digital twinsHossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell, et al.
Dermatology and Therapy|May 11, 2023
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL StudyKalyani Marathe, Joyce M C Teng, Scott Guenthner, et al.
The British Journal of Dermatology|January 23, 2023
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE studyJohannes S Kern, Eli Sprecher, Maria Florencia Fernandez, et al.
Clinical and Experimental Dermatology|February 16, 2023
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosisDedee F Murrell, Joyce M C Teng, Scott Guenthner, et al.
The British Journal of Dermatology|May 28, 2014
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trialD M Rubel, L Spelman, D F Murrell, et al.
International Journal of Dermatology|September 27, 2014
Diffuse melanosis cutis in the setting of BRAF(V600E) metastatic melanomaDeshan F Sebaratnam, Linda K Martin, Supriya S Venugopal, et al.
The Journal of Pathology|December 31, 2013
Flightless I over-expression impairs skin barrier development, function and recovery following skin blisteringZlatko Kopecki, Gink N Yang, Ruth M Arkell, et al.
Pageof 50

Showing results (381-390 of 491) with videos related to

Sort By:
Pageof 50
NPJ Systems Biology and Applications|October 3, 2025
Enhancing randomized clinical trials with digital twinsHossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2021
Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicM Kasperkiewicz, E Schmidt, M Amagai, et al.
The Australasian Journal of Dermatology|April 2, 2015
Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological studyLynda Spelman, Diana Rubel, Dedee F Murrell, et al.
NPJ Systems Biology and Applications|November 6, 2025
Author Correction: Enhancing randomized clinical trials with digital twinsHossein Akbarialiabad, Amirmohammad Pasdar, Dédée F Murrell, et al.
Dermatology and Therapy|May 11, 2023
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL StudyKalyani Marathe, Joyce M C Teng, Scott Guenthner, et al.
The British Journal of Dermatology|January 23, 2023
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE studyJohannes S Kern, Eli Sprecher, Maria Florencia Fernandez, et al.
Clinical and Experimental Dermatology|February 16, 2023
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosisDedee F Murrell, Joyce M C Teng, Scott Guenthner, et al.
The British Journal of Dermatology|May 28, 2014
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trialD M Rubel, L Spelman, D F Murrell, et al.
International Journal of Dermatology|September 27, 2014
Diffuse melanosis cutis in the setting of BRAF(V600E) metastatic melanomaDeshan F Sebaratnam, Linda K Martin, Supriya S Venugopal, et al.
The Journal of Pathology|December 31, 2013
Flightless I over-expression impairs skin barrier development, function and recovery following skin blisteringZlatko Kopecki, Gink N Yang, Ruth M Arkell, et al.
Pageof 50